Malakoplakia, a rare granulomatous disease of infectious etiology, is commonly observed in immunocompromised patients. Chronic lymphocytic leukemia (CLL) is characterized by profound immune dysregulation resulting in significant infection-related morbidity and mortality, and several drugs used in CLL treatment have a severe immunosuppressive effect. Ibrutinib, has become a new standard-of-care in patients with CLL, especially for those harboring unfavorable genetic characteristics such as 17 p deletion, with however, unknown long-term immunological consequences. Here we report a case of a patient with CLL with 17 p deletion diagnosed with malakoplakia of the urinary bladder under ibrutinib therapy who developed severe hypogammaglobulinemia during treatment administration. Presumably, ibrutinib might contribute to the development of malakoplakia on the grounds of induced immunosuppression. This case report highlights the need for regular assessment of immunogammaglobulin adequacy during treatment with ibrutinib, considering that it should be given on a permanent basis.

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11032DOI Listing

Publication Analysis

Top Keywords

malakoplakia urinary
8
urinary bladder
8
chronic lymphocytic
8
lymphocytic leukemia
8
ibrutinib therapy
8
case report
8
ibrutinib
5
malakoplakia
4
bladder patient
4
patient chronic
4

Similar Publications

Recurrent bladder malakoplakia: A rare bladder lesion mimicking malignancy.

Bladder (San Franc)

November 2024

Department of Pathology and Laboratory Medicine, Brantford General Hospital, Brantford, Ontario N3R 1G9, Canada.

Background: Malakoplakia is a rare granulomatous disease that commonly involves the genitourinary tract with the urinary bladder being the most frequently affected site. It is characterized by histiocytes containing distinct basophilic calcified inclusions called Michaelis-Gutmann bodies. It is believed to result from abnormally functioning macrophages, with inclusions representing calcifications around incompletely digested bacteria.

View Article and Find Full Text PDF

Malakoplakia in a Transplanted Liver.

ACG Case Rep J

September 2024

Department of Gastroenterology and Hepatology, Cleveland Clinic, Weston, FL.

Article Synopsis
  • Malakoplakia is a rare condition that typically affects the urinary bladder, but there have been only 8 reported cases involving the liver, with this being the first in a transplanted liver.
  • A 63-year-old man with a history of liver transplantation presented with fever, chills, and abdominal pain, leading to imaging that revealed persistent microabscesses in his liver despite antibiotic treatment.
  • Surgical intervention involved a hepatectomy to remove the affected segment, and the examination of tissue samples confirmed the presence of malakoplakia.
View Article and Find Full Text PDF
Article Synopsis
  • * The condition commonly affects the urinary tract and gastrointestinal tract, particularly the colon and rectum, and is seldom seen in children.
  • * Treatment involves using specific antibiotics that target macrophages and cholinergic agents to enhance the immune response, with a reported case in a pediatric leukemia patient highlighting its rarity.
View Article and Find Full Text PDF
Article Synopsis
  • - Malakoplakia is a rare type of inflammation mainly seen in the urinary bladders of dogs, with only one previous case reported in the colon.
  • - A 5-month-old spayed female French Bulldog was diagnosed with colonic malakoplakia after showing symptoms like chronic diarrhea and blood in feces, which did not improve with initial treatments.
  • - The dog showed significant recovery after 8 months of treatment with enrofloxacin, with noticeable progress after just 2 months.
View Article and Find Full Text PDF
Article Synopsis
  • Malakoplakia is a rare disease that causes chronic inflammation, usually in the urogenital organs, and can be diagnosed by looking for special bodies called Michaelis-Gutmann bodies.
  • In this case, a patient was wrongly diagnosed with advanced ovarian cancer but actually had malakoplakia along with an ovarian tumor that created a connection to her skin.
  • After surgery to remove the problematic tissue, she took antibiotics for six months and showed no signs of the disease coming back after two years.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!